Gelida joins early detection program for cervical cancer using self-sampling

Women aged 30-65 will receive an SMS to perform the HPV test at home, facilitating early detection and work-life balance.

Generic image of a medical self-sampling kit with instructions.
AI

Generic image of a medical self-sampling kit with instructions.

The Department of Health has expanded the Early Detection Program for Cervical Cancer to Gelida and ten other municipalities in Baix Llobregat Nord. Starting in November, women aged 30 to 65 will receive an SMS to perform a self-sample for the human papillomavirus (HPV) at home.

The program, coordinated by the Institut Català d’Oncologia, incorporates the human papillomavirus (HPV) detection test for women and individuals with a cervix aged 30 to 65. This initiative reaches Abrera, Castellví de Rosanes, Collbató, Esparreguera, Gelida, Masquefa, Olesa de Montserrat, Pallejà, Sant Andreu de la Barca, Sant Esteve Sesrovires, and Sant Llorenç d’Hortons, in addition to Martorell, which began weeks ago. Women will receive an SMS from the Department of Health when it's time for their test.
The SMS invites recipients to collect the necessary materials and instructions for self-sampling free of charge at a pharmacy. Once collected, the sample is returned to the pharmacy for analysis. Pharmacies facilitate an accessible system, and their professionals are trained to resolve queries. Contact can also be made with the Cervical Cancer Screening Technical Office of the ICO at 93 260 74 69 or prevenciocervix@iconcologia.net.
Results are notified via SMS within a maximum of 30 days and can be consulted on La Meva Salut. A negative result means the test is repeated every 5 years. A positive result will require an in-person visit to a Sexual and Reproductive Health Care (ASSIR) center for further testing.
The Barcelona Metropolitan South health region is a pioneer in this rollout. Population screening with self-sampling began in Catalonia in early 2024 and has been gradually extended. With the incorporation of these municipalities, the program will be fully implemented in the region, with progressive implementation planned for the rest of Catalonia in the coming years.
HPV, a common sexually transmitted infection, is a necessary cause of cervical cancer, although most infections clear on their own. Persistent infection can lead to precancerous lesions. The HPV detection test is safer and more sensitive than cytology, allowing for longer intervals of 5 years between negative tests and reducing the incidence of cervical cancer by 60% to 70%.
Catalonia is thus aligning with the global strategy of the World Health Organization (WHO) for the elimination of cervical cancer. The region already includes the HPV vaccine in its systematic vaccination schedule for boys and girls.
Based on information from the official source: Ajuntament de Gelida (19/11/2026)